See you there? 🤩

First original research article as a lab leader, and the first one from research at Leinonen Retina Laboratory! Big thanks to Wipf Group for great collaboration!

Here we present a drug repurposing strategy to treat retinal degenerations. Our treatment slows retinal degeneration in an etiology-independent manner in several distinct disease models. Next milestone: clinical trial in human patients. nature.com/articles/s4146…

DYK: NEI seeks to support early-stage clinical trials (e.g., Phase I or II with strong preclinical or preliminary data) through a new program. Budgets are not limited but need to reflect needs of the proposed project. Details: grants.nih.gov/grants/guide/p…

uef.fi/fi/artikkeli/l…

I am pleased to share our recent publication at Leinonen Retina Laboratory and my second postdoctoral publication. uef.fi/en/article/ana… Many thanks to Henri Leinonen , Leinonen Retina Laboratory , and our collaborators at UCI Health Gavin Herbert Eye Institute and University of Ottawa

New paper put from our lab! Big congratulations and thanks to first author Dr Ahmed Montaser, et al! uef.fi/en/article/ana…

Academy Research Fellow Henri Leinonen at the UEF School of Pharmacy is the 1st Finnish researcher recognised with the FEBS Excellence Award of the Federation of European Biochemical Societies. Congrats! FEBS Henri Leinonen @uef_farmasia @UEF_DrugTech uef.fi/en/article/hen…

Its fascinating to attend #hupo2024, present your work, and interact with proteomics enthusiasts #YPIC #ECR

Congratulations to Henri Leinonen of the University of Eastern Finland, Kuopio, Finland, on being awarded a FEBS Excellence Award, which provides €100,000 in research funding Henri Leinonen Leinonen Retina Laboratory #FEBSExcellenceAwards febs.org/news/febs-exce…

This is HUGE for all working on drug repurposing! A must read/skim through! Congratulations for the REMEDi4ALL team and other authors!

Big bucks this time! Great gratitude to Jane & Aatos Erkko Foundation for super-powering our research 2026-2029 with close to 1 m€! Big thanks to the Leinonen Retina Laboratory members for enabling this!

Check out our outreach article explaining how old drugs could ”get a new life”, be repurposed to a new type of use (new indication), and change lives of people suffering from currently untreatable diseases.

Full week of learning about the retina in the FASEB Biology and Chemistry of Vision conference is coming to an end! Always so educative! Till next time (2027)? 🙂 #research #Science #vision

Check out our new perspective article about cAMP and/or cGMP inhibition as a potential solution to address unmet therapeutic need in retinitis pigmentosa. Very proud of PhD student Katri V and PhD Ahmed M (and myself :)) of putting this together. #vision

What a week in Prague at #RD2025! 🚀 Keynotes on gene therapy, proteomics & adaptive optics OCT, new insights into degeneration pathways, and exciting advances in cell & drug therapies. Grateful to be part of such a collaborative and forward-looking retinal research community!